To assess this issue experimentally, we undertook a large in vivo interventional study involving two genetically-modified mouse models representing early-stage benign (Pb-Prl) and (pre-) malignant (KIMAP) prostate tumorigenesis. Here, PRL is linked to male reproductive organ cancer.